Scancell【SCLP】銘柄情報

Scancell Hldgs Plc (SCLP) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

21.75

( -2.25% )

買値

21.50

売値

22.00

出来高

485,647

21.75 日の範囲 22.50

7.90 52 週間の範囲 29.50

時価総額

225.717M

前日終値

22.25

始値

22.25

時刻

13480

21.5

(O)

最終取引時間

18:45:38

財務取引量

VWAP

平均取引量 (3 か月)

2,070,261p

発行済株式数

1,037,781,403

配当利回り

PER

-31.65

1 株当たり利益 (EPS)

-0.01

歳入

4.71M

純利益

-5.51M

Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of ... Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase II clinical trials for the treatment of solid tumors, including renal, head and neck, ovarian and triple negative breast cancers; and Modi-2, which targets stress-induced post translational modifications, such as homocittrullination. In addition, the company provides GlyMab platform that generates various affinity tumour specific monoclonal antibodies (mAb) targeting glycans that are over-expressed on cancer cells; and AvidiMab, which romotes receptor clustering thereby improving immune signalling. Scancell Holdings plc was founded in 1996 and is based in Oxford, the United Kingdom. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.scancell.co.uk

本社

Oxford, United Kingdom

設立

1996

Scancell Hldgs Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker SCLP. The last closing price for Scancell was 22.25p. Over the last year, Scancell shares have traded in a share price range of 7.90p to 29.50p.

Scancell currently has 1,037,781,403 shares in issue. The market capitalisation of Scancell is £225.72 million. Scancell has a price to earnings ratio (PE ratio) of -31.65.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-2	-8.42105263158	23.75	23.75	21.5	1106942	22.36001076	DE
4	3.5	19.1780821918	18.25	29.5	18.25	3315417	23.08090987	DE
12	9	70.5882352941	12.75	29.5	11	2134782	18.69460865	DE
26	11.95	121.93877551	9.8	29.5	9.75	1769600	15.82303459	DE
52	11.25	107.142857143	10.5	29.5	7.9	1341099	13.6744488	DE
156	7.275	50.2590673575	14.475	29.5	7.25	958007	12.82481838	DE
260	-1.25	-5.4347826087	23	29.5	7.25	917585	14.90510185	DE